ZA200900426B - Treatment of cartilage disorders with FGF-18 - Google Patents

Treatment of cartilage disorders with FGF-18

Info

Publication number
ZA200900426B
ZA200900426B ZA200900426A ZA200900426A ZA200900426B ZA 200900426 B ZA200900426 B ZA 200900426B ZA 200900426 A ZA200900426 A ZA 200900426A ZA 200900426 A ZA200900426 A ZA 200900426A ZA 200900426 B ZA200900426 B ZA 200900426B
Authority
ZA
South Africa
Prior art keywords
fgf
treatment
cartilage disorders
cartilage
disorders
Prior art date
Application number
ZA200900426A
Inventor
Alberto Gimona
Christoph H Ladel
Baur Elmar Vom
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of ZA200900426B publication Critical patent/ZA200900426B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200900426A 2006-08-25 2007-08-24 Treatment of cartilage disorders with FGF-18 ZA200900426B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06119557 2006-08-25

Publications (1)

Publication Number Publication Date
ZA200900426B true ZA200900426B (en) 2010-04-28

Family

ID=37684849

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200900426A ZA200900426B (en) 2006-08-25 2007-08-24 Treatment of cartilage disorders with FGF-18

Country Status (11)

Country Link
CN (1) CN101505787B (en)
BR (1) BRPI0715728A8 (en)
DK (1) DK2054050T3 (en)
ES (1) ES2392883T3 (en)
MY (1) MY148277A (en)
NZ (1) NZ574216A (en)
PT (1) PT2054050E (en)
RS (1) RS52710B (en)
SI (1) SI2054050T1 (en)
UA (1) UA99818C2 (en)
ZA (1) ZA200900426B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10221456B2 (en) * 2012-08-06 2019-03-05 Merck Patent Gmbh Genetic markers for predicting responsiveness to FPG-18 compound
EP3107592B1 (en) * 2014-02-20 2018-08-22 Merck Patent GmbH Implant comprising fgf-18
US20170056554A1 (en) * 2014-02-20 2017-03-02 Merck Patent Gmbh Fgf-18 in graft transplantation and tissue engineering procedures
AR099510A1 (en) * 2014-02-20 2016-07-27 Merck Patent Gmbh FGF-18 COMPOSITE DOSAGE REGIME
EP3250223A1 (en) * 2015-01-08 2017-12-06 University of Iowa Research Foundation Methods for the regeneration of articular cartilage in vivo
JP6951318B2 (en) * 2015-07-15 2021-10-20 プロージット ソウル バイオテクノロジー （ベイジン） カンパニー リミテッド Fusion polypeptide and usage
WO2017025611A1 (en) * 2015-08-13 2017-02-16 Merck Patent Gmbh Combination composition comprising fgf-18 compound
US11904006B2 (en) 2019-12-11 2024-02-20 University Of Iowa Research Foundation Poly(diaminosulfide) particle-based vaccine
CN117721115A (en) * 2022-09-06 2024-03-19 深圳瑞吉生物科技有限公司 mRNA for treating osteoarthritis and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4754823B2 (en) * 2002-10-07 2011-08-24 ザイモジェネティクス， インコーポレイテッド Administration method of FGF18
EP1896053B1 (en) * 2004-07-06 2018-10-31 ZymoGenetics, Inc. Pharmaceutical composition comprising fgf18 and il-1 antagonist and method of use
CA2592261C (en) * 2004-12-10 2015-11-24 Zymogenetics Inc. Fgf18 production in prokaryotic hosts

Also Published As

Publication number Publication date
NZ574216A (en) 2011-11-25
SI2054050T1 (en) 2012-12-31
PT2054050E (en) 2012-09-17
UA99818C2 (en) 2012-10-10
BRPI0715728A8 (en) 2018-04-03
RS52710B (en) 2013-08-30
ES2392883T3 (en) 2012-12-14
MY148277A (en) 2013-03-29
BRPI0715728A2 (en) 2013-09-17
DK2054050T3 (en) 2012-09-03
CN101505787B (en) 2013-09-04
CN101505787A (en) 2009-08-12

Similar Documents

Publication Publication Date Title
PL2054050T3 (en) Treatment of cartilage disorders with fgf-18
EP1981526A4 (en) Adiponectin for treatment of various disorders
IL197001A0 (en) Combination treatment for metabolic disorders
IL194189A0 (en) Combination treatment of metabolic disorders
IL230335A (en) Composition for treatment of cartilage disease
ZA200900426B (en) Treatment of cartilage disorders with FGF-18
GB0703909D0 (en) Treatment of anxiety disorders
ZA200903772B (en) Treatment of pervasive developmental disorders
IL195906A0 (en) Alpha-aminoamide derivatives useful in the treatment of cognitive disorders
HK1247943A1 (en) Treatment of development-related disorders
IL198196A0 (en) Treatment of demyelinating disorders with soluble lymphotoxin-beta-receptor
GB0619500D0 (en) Treatment of fibrosis
GB0607952D0 (en) Novel treatment
EP2037943A4 (en) Treatment of connective tissue disorders
PL1982178T3 (en) Methods for the treatment of affective disorders
GB0604460D0 (en) Treatment
GB0623740D0 (en) Treatment of disease
HK1145282A1 (en) Treatment of sleep disorders
GB0602857D0 (en) The treatment of sialorrhoea
ZA200902765B (en) Treatment of pulp
GB0624439D0 (en) Technique for treatment of gall-and kidney-stones
GB0625602D0 (en) Treatment of sialorrhoea
GB0618705D0 (en) Treatment of joint disorders
GB0619218D0 (en) Treatment of conformational disorders
GB0602858D0 (en) The treatment of sialorrhoea